Frontiers in Pharmacology (Nov 2019)

Comparative Network Pharmacology Analysis of Classical TCM Prescriptions for Chronic Liver Disease

  • Zikun Chen,
  • Xiaoning Wang,
  • Yuanyuan Li,
  • Yahang Wang,
  • Kailin Tang,
  • Dingfeng Wu,
  • Wenyan Zhao,
  • Yueming Ma,
  • Ping Liu,
  • Ping Liu,
  • Zhiwei Cao

DOI
https://doi.org/10.3389/fphar.2019.01353
Journal volume & issue
Vol. 10

Abstract

Read online

Chronic liver disease (CLD) has become a major global health problem while herb prescriptions are clinically observed with significant efficacy. Three classical Traditional Chinese Medicine (TCM) formulae, Yinchenhao Decoction (YCHT), Huangqi Decoction (HQT), and Yiguanjian (YGJ) have been widely applied in China to treat CLD, but no systematic study has yet been published to investigate their common and different mechanism of action (MOA). Partial limitation may own to deficiency of effective bioinformatics methods. Here, a computational framework of comparative network pharmacology is firstly proposed and then applied to herbal recipes for CLD disease. The analysis showed that, the three formulae modulate CLD mainly through functional modules of immune response, inflammation, energy metabolism, oxidative stress, and others. On top of that, each formula can target additional unique modules. Typically, YGJ ingredients can uniquely target the ATP synthesis and neurotransmitter release cycle. Interestingly, different formulae may regulate the same functional module in different modes. For instance, YCHT and YGJ can activate oxidative stress-related genes of SOD family while HQT are found to inhibit SOD1 gene. Overall, our framework of comparative network pharmacology proposed in our work may not only explain the MOA of different formulae treating CLD, but also provide hints to further investigate the biological basis of CLD subtypes.

Keywords